TotalMarketCap

Jupiter Neurosciences

JUNSNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$2.881 M

$2.19 -4.17%

Close of 6 Nov 2026

As of 6 Nov 2026, Jupiter Neurosciences (JUNS) has a market capitalization of $2.88M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$21.8K

#3599 by revenue

Earnings

-$8.64M

Loss-making

Shares outstanding

770,081

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #472Kala BioKALA$2.95M
  2. #473Clearmind MedicineCMND$2.90M
  3. #474Jupiter NeurosciencesJUNS$2.88M
  4. #475NeuroSense TherapeuticsNRSN$2.75M
  5. #476Decoy TherapeuticsDCOY$2.70M

What if Jupiter Neurosciences were worth as much as…

Open the what-if tool →

Gold $28.2T

$21,415,569

Per share 9,801,176× higher

Bitcoin $1.53T

$1,158,759

Per share 530,325× higher

Apple $5.02T

$3,804,098

Per share 1,741,006× higher

Or at a round number

$5.00M$10.0M$20.0M$50.0M

Where these numbers come from

Share counts and financials for Jupiter Neurosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.